Biogen is making a few changes to its C-suite. The drugmaker will bring on Bristol Myers Squibb exec Daniel Quirk as chief medical officer and head of medical affairs, a move announced one day after ...

Modernization of “manufacturing technologies and controls through further advanced automation and artificial intelligence” are helping trigger Biogen’s commitment of $2 billion into its North Carolina ...

FILE - This image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. (Biogen via AP, File) Author: CBS News, Kate Gibson, Anne Marie Lee Published: 3:29 PM ...

The biotechnology pioneer now expects revenue to be flat at constant currency versus last year. It previously forecast a mid-single digit decline. The company also expects adjusted earnings per-share ...

Idec Pharmaceuticals Corp. and Biogen Inc. announced yesterday that they would merge in a $6.8 billion deal that will create a powerhouse in the biotechnology industry, with the new company ...

Food For Free, a 501(c)(3) that "rescues" food from places like corporate cafeterias and university dining halls and redistributes it to folks in need, has partnered with Biogen Inc. (Nasdaq: BIIB ...

BOLD TYPES Biogen CEO tells Governor Healey he’s concerned about ‘a lot more policy risk’ in D.C. By Jon Chesto Globe Staff,Updated January 24, 2025, 9:03 a.m.

Biogen Inc. is now projecting a better-than-expected 2024 as the company continues to see an uptick in sales from Leqembi, the Alzheimer's disease drug it developed in partnership with Eisai Inc.

Biogen Inc. BIIB on Wednesday reported third quarter results that topped analyst estimates, even as it navigates a complex launch of its new Alzheimer’s treatment Leqembi. The biotech company ...